Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
McGill University and Genome Quebec Innovation Centre, Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Nat Genet. 2018 Oct;50(10):1375-1380. doi: 10.1038/s41588-018-0211-z. Epub 2018 Sep 17.
Efforts are being directed to systematically analyze the non-coding regions of the genome for cancer-driving mutations. cis-regulatory elements (CREs) represent a highly enriched subset of the non-coding regions of the genome in which to search for such mutations. Here we use high-throughput chromosome conformation capture techniques (Hi-C) for 19,023 promoter fragments to catalog the regulatory landscape of colorectal cancer in cell lines, mapping CREs and integrating these with whole-genome sequence and expression data from The Cancer Genome Atlas. We identify a recurrently mutated CRE interacting with the ETV1 promoter affecting gene expression. ETV1 expression influences cell viability and is associated with patient survival. We further refine our understanding of the regulatory effects of copy-number variations, showing that RASL11A is targeted by a previously identified enhancer amplification. This study reveals new insights into the complex genetic alterations driving tumor development, providing a paradigm for employing chromosome conformation capture to decipher non-coding CREs relevant to cancer biology.
目前正在努力系统地分析基因组中非编码区域中的致癌突变。顺式调控元件 (CRE) 是基因组非编码区域中高度富集的一个子集,可在其中搜索此类突变。在这里,我们使用高通量染色体构象捕获技术 (Hi-C) 对 19,023 个启动子片段进行分析,以绘制结直肠癌细胞系中的调控图谱,绘制 CRE 图谱,并将这些图谱与全基因组序列和癌症基因组图谱中的表达数据进行整合。我们鉴定了一个与 ETV1 启动子相互作用并影响基因表达的复发性突变 CRE。ETV1 表达影响细胞活力并与患者生存相关。我们进一步深入了解拷贝数变异的调控作用,表明 RASL11A 是先前鉴定的增强子扩增的靶标。这项研究揭示了驱动肿瘤发展的复杂遗传改变的新见解,为利用染色体构象捕获来破译与癌症生物学相关的非编码 CRE 提供了范例。